Context Therapeutics Inc. — Director's Dealing 2023

May 31, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Context Therapeutics Inc. (CNTX)
CIK: 0001842952
Period of Report: 2023-05-31

Reporting Person: West Linda (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-05-31	Stock Option (right to buy)	$0.87	A	25000	Acquired	2033-05-30	Common Stock (25000.0)	Direct

Footnotes

F1: The option vests and becomes exercisable on the earlier of (i) May 31, 2024 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2024 annual meeting of stockholders, subject to continued service with the Issuer.